Asunto(s)
Negro o Afroamericano/estadística & datos numéricos , COVID-19/etnología , COVID-19/mortalidad , Asistencia Sanitaria Culturalmente Competente/métodos , Disparidades en Atención de Salud/etnología , Disparidades en el Estado de Salud , Humanos , SARS-CoV-2 , Estados Unidos/epidemiología , Población Blanca/estadística & datos numéricosAsunto(s)
Población Negra/psicología , Vacunas contra la COVID-19 , COVID-19/prevención & control , Asistencia Sanitaria Culturalmente Competente/etnología , Disparidades en Atención de Salud/etnología , Negativa a la Vacunación/etnología , Vacunación , Población Negra/estadística & datos numéricos , COVID-19/etnología , COVID-19/psicología , Canadá , Asistencia Sanitaria Culturalmente Competente/métodos , Empoderamiento , Promoción de la Salud/métodos , Accesibilidad a los Servicios de Salud , Disparidades en el Estado de Salud , Humanos , Participación del Paciente/métodos , Participación del Paciente/psicología , Relaciones Profesional-Paciente , Racismo/psicología , Confianza/psicología , Vacunación/métodos , Vacunación/psicología , Vacunación/tendencias , Negativa a la Vacunación/psicología , Negativa a la Vacunación/tendenciasAsunto(s)
COVID-19 , Asistencia Sanitaria Culturalmente Competente , Hispánicos o Latinos , Trastornos Mentales , Telemedicina , COVID-19/epidemiología , COVID-19/psicología , Asistencia Sanitaria Culturalmente Competente/métodos , Asistencia Sanitaria Culturalmente Competente/organización & administración , Educación en Salud/métodos , Necesidades y Demandas de Servicios de Salud , Disparidades en Atención de Salud , Hispánicos o Latinos/psicología , Hispánicos o Latinos/estadística & datos numéricos , Humanos , Trastornos Mentales/etnología , Trastornos Mentales/psicología , Trastornos Mentales/terapia , Salud Mental/etnología , Participación del Paciente/métodos , SARS-CoV-2 , Telemedicina/métodos , Telemedicina/organización & administración , Estados UnidosAsunto(s)
COVID-19 , Asistencia Sanitaria Culturalmente Competente/métodos , Educación Médica/métodos , Dominio Limitado del Inglés , COVID-19/epidemiología , Curriculum , Accesibilidad a los Servicios de Salud , Humanos , Pandemias , SARS-CoV-2 , Facultades de Medicina/organización & administración , Estados Unidos/epidemiologíaRESUMEN
If we were told that one day the entire world would take its guidance for managing a health crisis from empirical thought, nobody would have believed it. However, with the December 2019 arrival of COVID-19 in China, the world subsequently went into a frenzied state that resulted in the widespread adoption of untested strategies or potential cures; circumstantial evidence provided without randomized control trials (RCTs) was published rapidly and widely considered the gold standard in medical research and therapeutics. Nigeria and much of the rest of the world blindly adopted treatments like chloroquine or hydroxychloroquine and various prevention strategies, often without monitoring the efficacy of these treatment and social control strategies. COVID-19 provided Nigeria a critical opportunity to create or strengthen its national laboratory system by building up its Level 3 laboratories in all parts of the country with the capability to perform PCR tests and viral isolation. There was also an opportunity to establish hospitals in every region of a sufficient standard to reduce the numbers of Nigerians travelling abroad to seek medical treatment; to invest in building capacity to develop antiviral medications and vaccines in Nigeria, and to ensure better international health policies. Rather, Nigerian leaders, government and health managers decided (like most other nations of the world) to shut down the society using isolationist policies that were not necessarily tailored to local needs. Despite adopting these methods, COVID-19 cases continued to skyrocket in Nigeria. In the future, before adopting such broad sweeping policies, there should be local tailoring to assess their effectiveness in different communities. Given that the country has much experience in controlling Lassa and Marburg Fever outbreaks, Nigeria should lead by developing new strategies, new protocols and new local guidelines, based on validated and reproducible studies to ensure that the public health authorities are not caught unaware by any new outbreaks of emerging or remerging diseases.
Asunto(s)
Tratamiento Farmacológico de COVID-19 , COVID-19 , Gestión del Cambio , Control de Enfermedades Transmisibles , Asistencia Sanitaria Culturalmente Competente , Formulación de Políticas , Salud Pública/normas , COVID-19/epidemiología , COVID-19/prevención & control , COVID-19/terapia , Defensa Civil/normas , Control de Enfermedades Transmisibles/métodos , Control de Enfermedades Transmisibles/organización & administración , Asistencia Sanitaria Culturalmente Competente/legislación & jurisprudencia , Asistencia Sanitaria Culturalmente Competente/métodos , Asistencia Sanitaria Culturalmente Competente/organización & administración , Regulación Gubernamental , Humanos , Nigeria/epidemiología , Distanciamiento Físico , SARS-CoV-2RESUMEN
As coronavirus disease 2019 (COVID-19) continues to impact the seriously ill and their families on a global scale, considerations given to marginalized groups amid the pandemic are essential to ensure the provision of high-quality and dignified care. Lesbian, gay, bisexual, transgender, gender-nonconforming, and queer/questioning-identified (LGBTQ+) persons are particularly vulnerable to health inequities across settings, including palliative care and at the end of life. There is a crucial gap in the literature pertaining to palliative care for LGBTQ+ populations during COVID-19. We aim to fill this gap by providing essential health inequity and social support background pertaining to LGBTQ+ persons and practical recommendations for immediate implementation that support inclusive and respectful care for these populations. Using these recommendations is a pragmatic pathway to promote trust, transparency, patient and family engagement, and value concordant care amid the health system strain caused by COVID-19.